Acadia Pharmaceuticals

1 similar search for Acadia Pharmaceuticals

ACADIA Pharmaceuticals, Inc.

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

667 documents for Acadia Pharmaceuticals

- ACADIA Pharmaceuticals Reports Third Quarter 2011 Financial Results.
SAN DIEGO -- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinic...
- Business Wire
- November 09, 2011
- ACADIA Pharmaceuticals Advances AM-831 to Phase I Clinical Development in Collaboration with Meiji Seika Pharma.
--FDA Accepts Investigational New Drug Application for AM-831-- SAN DIEGO -- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company...
- Business Wire
- November 07, 2011
- ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2011.
SAN DIEGO -- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs...
- Business Wire
- March 06, 2012

- ACADIA Pharmaceuticals Announces $15 Million Private Placement.
--Proceeds to Support Advancement of Pimavanserin Phase III Program-- SAN DIEGO -- ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical co...
- Business Wire
- January 10, 2011
- ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2010.
SAN DIEGO -- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinic...
- Business Wire
- March 10, 2011
- ACADIA Pharmaceuticals Announces Extension of Drug Discovery Collaboration with Allergan, Inc.
SAN DIEGO -- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinic...
- Business Wire
- April 01, 2011
- ACADIA Pharmaceuticals Reports Second Quarter 2010 Financial Results.
SAN DIEGO -- ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinica...
- Business Wire
- August 09, 2010
- ACADIA Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12, 2011.
SAN DIEGO -- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinic...
- Business Wire
- September 06, 2011
- ACADIA Pharmaceuticals Enters Agreement with Biovail to Conclude Collaboration and Regain North American Rights to Pimavanserin.
ACADIA Now Holds Worldwide Rights; Receives $8.75 Million Payment to Continue Ongoing Phase III Trials in Parkinson's Disease Psychosis ACADIA Confe...
- Business Wire
- October 28, 2010
- ACADIA Pharmaceuticals Reports First Quarter 2010 Financial Results.
SAN DIEGO -- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinic...
- Business Wire
- May 10, 2010